Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...

Odd chemical pathways can give completely unexpected makeovers to some of the most troublesome waste; take, for example, an ...

Altimmune's pemvidutide targets MASH with dual glucagon/GLP-1 biology, showing mid-stage promise as it advances toward a high-stakes phase III study.

Matcha and chamomile are trending together. But is there science behind it? Nutrition experts break down how this pairing of ...

India has emerged as a credible voice across the world for climate justice, equity and sustainable development, demonstrating that conservation and climate action are ...

Merck & Company Inc (NYSE:MRK) has announced a major acquisition involving Terns Pharmaceuticals, marking an important ...

The next phase of weight management won’t be led by pharma, but by functional foods designed to work alongside GLP‑1 drugs, ...

Baidam is growing at a significant rate, having internally promoted senior staff to leadership roles. As well as expanding its footprint through new hires, training initiatives and the potential use ...

Obesity and appetite research reveals that ‘tanycytes’ detect glucose to trigger fullness, offering a novel target for weight ...

A new review looks at how probiotics, prebiotics, dietary changes, and fecal microbiota transplants can help support gut ...

In an era where blood-sugar supplements flood the market with exaggerated promises, Gluco Armor stands out for an ...

Your brain’s “stop eating” signal may come from an unexpected source. Researchers found that astrocytes—once thought to just support neurons—actually play a key role in controlling appetite. After a ...